What's Happening?
Greatly Health, a healthtech company, has raised $4 million in seed funding to expand its integrative oncology platform. The company aims to address the 'access gap' in integrative therapies, such as nutrition and exercise, which are often inaccessible
to patients outside major academic institutions. Founded by Chip Stine and MSK leaders Dr. Jun Mao and Dr. Robert Daly, Greatly Health's platform offers virtual, whole-person care, integrating supportive therapies into standard cancer treatment. The funding will be used to enhance the platform, expand the clinical team, and broaden the range of evidence-based therapies offered.
Why It's Important?
The expansion of Greatly Health's integrative oncology platform represents a significant shift towards more holistic cancer care. By making integrative therapies more accessible, the company addresses a critical gap in cancer treatment, potentially improving patient outcomes and reducing hospitalizations. This development aligns with broader industry trends towards functional and lifestyle medicine, as evidenced by initiatives like CMS's MAHA ELEVATE. The success of Greatly Health's model could influence healthcare providers and insurers to adopt similar approaches, integrating these therapies into standard care and potentially reducing overall healthcare costs.
